What Is Genetic Testing IVF Miami: A Complete Guide
Table of Contents
- Understanding Genetic Testing for IVF in Miami, Florida
- The Fundamentals of Preimplantation Genetic Testing in IVF
- Comparing PGT-A, PGT-M, and PGT-SR: A Detailed Look
- Who Can Benefit from Genetic Testing and What to Expect
- Advanced Considerations in Embryo Genetic Testing
- Common Questions About Genetic Testing for IVF
- Your Journey to Informed Fertility Decisions
Understanding Genetic Testing for IVF in Miami, Florida
When exploring IVF in Miami, Florida, genetic testing for IVF can help you make informed decisions about your embryos. It screens embryos for chromosomal abnormalities before transfer, improving your chance of a healthy pregnancy. We follow ACOG’s embryo genetic testing guidelines to guide your choices.
The primary form is preimplantation genetic testing (PGT), with two main types: PGT-A and PGT-M. PGT-A checks the chromosome number to improve implantation and reduce miscarriage risk. PGT-M looks for specific inherited conditions when a family risk is present. We discuss both openly at our South Florida practice.
- PGT-A – Screens for chromosome number errors, helping select embryos with the highest potential for a successful pregnancy and reducing miscarriage.
- PGT-M – Detects single-gene disorders, such as cystic fibrosis or sickle cell disease, when a known mutation is present.
At First Class OBGYN, we provide personalized counseling to help you decide if genetic testing for IVF fits your plan. Whether you visit our Miramar, Weston, or Pembroke Pines office, our team provides the expert attentive care you need to feel confident.
In the next section, “The Benefits and Process of Genetic Testing During IVF,” we’ll cover how genetic testing can support your pregnancy and what to expect during testing.
The Fundamentals of Preimplantation Genetic Testing in IVF
When considering genetic testing IVF in Miami, many patients turn to us for compassionate, evidence-based answers. Preimplantation genetic testing is an advanced embryo screening tool used during in vitro fertilization (IVF) to identify chromosomal or genetic abnormalities before embryo transfer. By biopsying a few cells from a day-5 or day-6 blastocyst, we can determine which embryos have the correct number of chromosomes and are free of specific inherited conditions.
This information allows us to select chromosomally normal embryos for transfer, which may improve implantation rates and lower the risk of miscarriage. (Results may vary based on individual patient conditions and circumstances.) The American College of Obstetricians and Gynecologists (ACOG) recognizes PGT as a valuable option for patients with recurrent pregnancy loss, advanced maternal age, or known genetic risks. The National Institutes of Health (NIH) supports the use of next-generation sequencing (NGS) for highly accurate embryo genetic analysis.
There are three main types of PGT: PGT-A, PGT-M, and PGT-SR. The table below highlights their purposes, techniques, and clinical indications.
| Type | Purpose | Technique | When Used |
|---|---|---|---|
| PGT-A | Screens embryos for aneuploidy (abnormal chromosome number) | Next-generation sequencing (NGS) or array CGH | Advanced maternal age, recurrent miscarriage, repeated IVF failure |
| PGT-M | Detects single-gene disorders (e.g., cystic fibrosis) | PCR-based methods with mutation-specific probes | Known carrier of a genetic disorder |
| PGT-SR | Identifies structural rearrangements (translocations) | NGS or array CGH with breakpoint analysis | Parental carrier of balanced translocation or inversion |
Sources: NIH, ACOG.
- PGT-A screens for aneuploidy using NGS or array CGH, ideal for recurrent miscarriage, advanced maternal age, and repeated IVF failure.
- PGT-M detects single-gene disorders via PCR-based methods, suited for known carriers or families with an inherited condition history.
- PGT-SR identifies structural chromosomal rearrangements with breakpoint analysis, appropriate when a parent carries a balanced translocation or inversion.
PGT-A (Aneuploidy Screening)
Preimplantation genetic testing PGT-A screens embryos for aneuploidy, an abnormal number of chromosomes, which is a leading cause of miscarriage and IVF failure. As maternal age increases, the incidence of aneuploidy rises, making this test particularly useful for women over 35. We perform the analysis using next-generation sequencing (NGS) or array comparative genomic hybridization (array CGH). For patients considering genetic testing for recurrent miscarriage, we often recommend PGT-A as part of a comprehensive fertility plan. It is also indicated for those who have experienced repeated unsuccessful IVF cycles.
PGT-M (Single-Gene Disorder Testing)
PGT-M genetic testing IVF identifies embryos affected by single-gene disorders such as cystic fibrosis, sickle cell disease, or Huntington’s disease. We use PCR-based methods with mutation-specific probes to determine whether an embryo carries the familial mutation. This test is recommended when one or both parents are known carriers of a genetic condition, or when there is a significant family history of an inherited disorder.
PGT-SR (Structural Rearrangement Testing)
PGT-SR is designed for parents who carry a balanced translocation or inversion — a rearrangement of chromosomal material that does not cause disease in the parent but can lead to unbalanced chromosomes in embryos. By applying NGS or array CGH with breakpoint analysis, we can identify embryos with the correct chromosomal structure, improving the likelihood of a healthy pregnancy.
Comparing PGT-A, PGT-M, and PGT-SR: A Detailed Look
When families explore genetic testing ivf miami, they often encounter three specialized screenings: PGT-A, PGT-M, and PGT-SR. Each type serves a distinct purpose, and recognizing the differences helps frame expectations for a successful cycle in South Florida.
| Feature | PGT-A | PGT-M | PGT-SR |
|---|---|---|---|
| Target | Aneuploidy | Single-gene mutations | Structural rearrangements |
| Methodology | NGS or array CGH | PCR based | NGS with breakpoint analysis |
| Risk of Mosaicism | Moderate | Low | Low |
| Turnaround Time | 7–10 days | 10–14 days | 10–14 days |
PGT-A: Screening for Chromosomal Normalcy
PGT-A, or preimplantation genetic testing for aneuploidy, evaluates embryos for whole chromosome gains or losses. This test uses next-generation sequencing (NGS) or array comparative genomic hybridization (array CGH). According to ACOG guidelines, PGT-A is especially relevant for patients over 35 or those with recurrent pregnancy loss. For patients who have pursued egg freezing in Weston, PGT-A can be performed on those frozen eggs after fertilization.
PGT-M: Targeting Specific Genetic Disorders
PGT-M screens embryos for single-gene mutations linked to inherited conditions such as cystic fibrosis, Huntington’s disease or sickle cell anemia. The procedure uses polymerase chain reaction (PCR) with custom mutation-specific probes. ACOG recommends pgt-m genetic testing ivf for couples known to carry pathogenic variants.
PGT-SR: Detecting Structural Rearrangements
PGT-SR targets embryos from couples where one partner carries a balanced translocation or inversion. The test employs NGS or array CGH with breakpoint analysis. ACOG guidelines indicate that PGT-SR can lower the incidence of miscarriage and improve outcomes for carriers of balanced rearrangements.
Who Can Benefit from Genetic Testing and What to Expect
Who Is a Candidate for Genetic Testing?
| Factor | Recommendation | PGT Type |
|---|---|---|
| Maternal age ≥35 | Offered screening for age-related aneuploidy | PGT-A |
| Recurrent miscarriage | Identify chromosomal causes | PGT-A / PGT-SR |
| Known carrier | Tailored to specific mutation | PGT-M |
How Long Does Genetic Testing Take?
Genetic analysis typically takes two to three weeks, depending on the type of PGT being performed. During this time, the embryos are safely frozen (cryopreserved) and remain viable for future transfer. We coordinate closely with the reference lab to minimize delays.
Genetic Testing for Recurrent Miscarriage: What the Evidence Shows
Multiple studies show that PGT-A can reduce miscarriage rates in couples with a history of recurrent loss by selecting euploid embryos. While no test can guarantee a successful pregnancy, using PGT-A may improve the chances of a chromosomally normal pregnancy.
Advanced Considerations in Embryo Genetic Testing
| Approach | Benefits | Limitations |
|---|---|---|
| No PGT | Lower cost, faster cycles | Higher miscarriage risk |
| PGT-A | Improves selection of euploid embryos | Mosaicism ambiguity |
Common Questions About Genetic Testing for IVF
PGT-A is not required for every cycle and many embryos are transferred without any testing. We find that when patients understand how results simply reorder which embryo to try first, they feel empowered to make a choice that fits their circumstances.
Your Journey to Informed Fertility Decisions
At First Class OBGYN, we're committed to helping you make informed fertility decisions with personalized, multilingual guidance in Miramar, Weston, and Pembroke Pines. Our team explains risks and benefits, but results vary and no test guarantees a pregnancy.